Jnj sotck.

Dec 1, 2023 · Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Mar 1, 2023 · Johnson & Johnson is well-prepared to weather a potential recession. See why I believe JNJ stock is an attractive low-risk pick in the current environment. Johnson & Johnson Stock Price, News & Analysis (NYSE:JNJ) $154.56 +2.45 (+1.61%) (As of 12:45 PM ET) Compare Today's Range $151.92 $154.58 50-Day …Key Points. Johnson & Johnson on Monday said it plans to reduce its stake in Kenvue by at least 80% via an exchange offer. The offer will allow J&J shareholders to swap all or a portion of their ...NVIDIA Corporation Common Stock $450.47 +0.42 +0.09% MSFT Microsoft Corporation Common Stock $352.60 -0.20 -0.06% Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours...

NEW BRUNSWICK, N.J., August 16, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders ...Dec 3, 2022 · As the stock currently trades, shares of JNJ pay an annual dividend of $4.52 which equates to a dividend yield of 2.53%. Over the past five years, the company has increased the dividend at an ...

Feb 27, 2023 · JNJ’s revenue is expected to increase 3.1% year-over-year to $97.85 billion in 2023. Its EPS is expected to grow 3.6% year-over-year to $10.52 in 2023. It surpassed EPS estimates in all four trailing quarters. JNJ’s shares have lost marginally intraday to close the last trading session at $155.97. JNJ’s POWR Ratings reflect this promising ... Review the current JNJ dividend history, yield and Johnson and Johnson stock split data to decide if it is a good investment for your portfolio this year.

Current and historical p/e ratio for Johnson & Johnson (JNJ) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.NEW BRUNSWICK, N.J., August 23, 2023 – Johnson & Johnson (NYSE: JNJ) today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) common stock owned by Johnson & Johnson. The exchange offer expired at …As the stock currently trades, shares of JNJ pay an annual dividend of $4.52 which equates to a dividend yield of 2.53%. Over the past five years, the company has increased the dividend at an ...Best Free Stock Trading Platforms. Best Robo-Advisors. Index Funds. ... Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its ...

May 4, 2023 · After the completion of the IPO, Johnson & Johnson will own 1,716,160,000 shares of Kenvue’s common stock, representing 91.9% of the total outstanding shares of Kenvue’s common stock. The consumer arm of JNJ is commonly known for its plasters, baby shampoo and Listerine brand of mouthwash.

Discover historical prices for JNJ stock on Yahoo Finance. View daily, weekly or monthly format back to when Johnson & Johnson stock was issued. ... Johnson & Johnson (JNJ) NYSE - NYSE Delayed ...

Johnson & Johnson Stock Earnings. The value each JNJ share was expected to gain vs. the value that each JNJ share actually gained. JNJ ( JNJ) reported Q3 2023 earnings per share (EPS) of $1.98, missing estimates of $2.52 by 21.38%. In the same quarter last year, JNJ 's earnings per share (EPS) was $1.68. JNJ is expected to release next earnings ...200% Stock Dividend: December 19, 1958: January 9, 1959: 2 1/2 for 1 Split: February 23, 1951: March 20, 1951: 5% Stock Dividend: ... At Johnson & Johnson, we promise ...In depth view into JNJ (Johnson & Johnson) stock including the latest price, news, dividend history, earnings information and financials.According to 13 analysts, the average rating for KVUE stock is "Buy." The 12-month stock price forecast is $26.82, which is an increase of 29.63% from the latest price. Price Target. $26.82 (29.63% upside) ... Other symbols: ARM BIRK CAVA GDHG JNJ NXT RIVN. 4 days ago - MarketBeat.MedTech. Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases.

As I pointed out in another article, I consider JNJ fully valued at about $170 to $180 per share, so the market has priced in a significant increase in talc-related liabilities, with the stock now ...13 Okt 2023 ... The Bottom Line. Johnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to ...Here’s what J&J reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv: Earnings per share: $2.66 ...The exchange offer provides a boon to J&J ( JNJ) shareholders as they would get Kenvue ( KVUE) stock at around a 7% discount. These shareholders would get $107.53 of Kenvue ( KVUE) common stock ...Get the latest Johnson & Johnson (JNJ) stock news and headlines to help you in your trading and investing decisions. Read Full Company Summary for JNJ here. View Johnson & Johnson JNJ investment & stock information. Get the latest Johnson & Johnson JNJ detailed stock …JNJ Stock Performances on October 12, 2023. On October 12, 2023, JNJ stock had a mixed performance, with some positive and negative indicators. Starting with the previous day’s close, JNJ stock closed at $156.18. The following day, the stock opened slightly lower at $155.89. Throughout the day, the stock had a range of $155.27 to $156.55.

Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Johnson & Johnson (JNJ) NYSE - NYSE Delayed ...

Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …See Johnson & Johnson (JNJ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... Johnson & Johnson (JNJ) NYSE - NYSE Delayed Price. Currency in USD. Follow ... Johnson & Johnson ( JNJ) spinout Kenvue ( NYSE: KVUE) saw its shares 22% Thursday after it raised $3.8B through the largest US initial public offering since 2021. Shares of Kenvue opened at $25.53 ...Dec 1, 2023 · Johnson & Johnson stock has received a consensus rating of buy. The average rating score is Aaa and is based on 36 buy ratings, 34 hold ratings, and 1 sell ratings. What was the 52-week low for ... When Johnson & Johnson (JNJ 0.32%) ... 10 stocks we like better than Johnson & Johnson When our award-winning analyst team has a stock tip, it can pay to listen. After all, ...JNJ stock analysts expected profit of $2.62 a share and $24.63 billion in sales. Pharmaceutical sales delivered most of the upside, Third Bridge's Brown said. Overall sales rose 3.1% to $13.73 ...Johnson & Johnson analyst ratings, historical stock prices, ... Stock Price Target JNJ. High $ 215.00: Median $ 172.00: Low $ 155.00: Average $ 175.42: Current Price $ 154.66: Related Links: Options;LMT | Complete Lockheed Martin Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Johnson & Johnson share price live 152.15, this page displays NYSE JNJ stock exchange data. View the JNJ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Johnson & Johnson real time stock price chart below. You can find more ...

NEW BRUNSWICK, N.J., August 16, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders ...

3.99%. Kenvue intends to pay out some of its cash to investors via dividends. The company recently initiated a $0.20 per share quarterly dividend ($0.80 annualized) that it will start paying in ...Stock Price Forecast. The 19 analysts offering 12-month price forecasts for Johnson & Johnson have a median target of 172.00, with a high estimate of 215.00 and a low estimate of 155.00. The median estimate represents a +8.59% increase from the last price of 158.39.Published July 24, 2023. Getty Images. Johnson & Johnson ( JNJ) will spin off at least 80.1% of its shares in consumer health company Kenvue ( KVUE) through an exchange offer, the company said ...Johnson & Johnson is well-prepared to weather a potential recession. See why I believe JNJ stock is an attractive low-risk pick in the current environment.Now, let's consider the immediate impact of the Kenvue spinoff. The midpoint of J&J's new full-year sales guidance, excluding consumer health, is $83.6 billion. That's compared to a midpoint of ...Stocks in Toronto were on the move upward Thursday to conclude a noteworthy November, led primarily ... Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Nov 19, 2020 · The second key opportunity stems from Johnson & Johnson’s valuation multiple compared to its peers. The stock now trades at 18x its projected 2020 adjusted earnings per share of about $8.01. In ... Stock near historical highs. The all-time high for JNJ stock is $147.36 per share, which is only just over 4% higher than its current share price of $140.69 per share. The high price of JNJ shares ...25 Okt 2023 ... We estimate Johnson & Johnson's Valuation to be $159 per share, reflecting only a 5% upside from its current levels of $151. Our forecast is ...

Once Johnson and Johnson splits, JNJ stock will only give traders and investors exposure to the medical device and pharmaceutical proceeds of the company. The new company, which will be listed as Kenvue, will trade separately. The JNJ split is expected to make more shareholder returns, as each business won’t be diluted by the …Johnson & Johnson share price live 152.15, this page displays NYSE JNJ stock exchange data. View the JNJ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Johnson & Johnson real time stock price chart below. You can find more ...Sep 16, 2021 · The stock price of Johnson & Johnson reached its all-time high of around $180 just last month before a recent sell-off in pharmaceutical stocks resulted in JNJ falling to $165 levels currently. Instagram:https://instagram. best cannibis stockgehc stock forecasttop 5 day trading platformsbest platform for trading futures Find the latest Enbridge Inc. (ENB) stock quote, history, news and other vital information to help you with your stock trading and investing. barron's dow jonesinstacard stock Nov 12, 2021 · Johnson & Johnson’s Covid vaccine is a minor part of its overall business — it is expected to bring in just $2.5 billion in revenue this year — but presented a high-profile opportunity for ... Stock Split Information table; Record Date Pay Out Date Action; May 22, 2001: June 12, 2001: 2 for 1 Split: May 21, 1996: June 11, 1996: 2 for 1 Split: May 19, 1992 forex trading mobile app Johnson & Johnson 52 week high is $181.04 as of December 03, 2023. What is the 52-week low for Johnson & Johnson? 52 week low is the lowest price of a stock in the past 52 weeks, or one year.Johnson & Johnson analyst ratings, historical stock prices, ... Stock Price Target JNJ. High $ 215.00: Median $ 172.00: Low $ 155.00: Average $ 175.42: Current Price $ 154.66: Related Links: Options;Currently, Johnson & Johnson’s price-earnings ratio is 32.2. Johnson & Johnson’s trailing 12-month revenue is $87.5 billion with a 35.5% profit margin. Year-over-year quarterly sales growth most recently was 6.8%. Analysts expect adjusted earnings to reach $10.056 per share for the current fiscal year.